Grand Pharma
Investor profile
Investment firm
Grand Pharma has backed 3 European tech companies across 3 funding rounds between 2022 and 2023, joining rounds totalling €120M. Most active in Healthtech. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2022–2023
2 yrs
Total round €
€120M
sum of rounds joined
Deals by year
distinct rounds / yearGrand Pharma — deals by year — interactive chart.
Data table
| Grand Pharma — deals by year | |
|---|---|
| 2022 | 2 |
| 2023 | 1 |
Top sectors
by dealsGrand Pharma — top sectors — interactive chart.
Data table
| Grand Pharma — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsGrand Pharma — stages — interactive chart.
Data table
| Grand Pharma — stages | |
|---|---|
| Series B | 1 |
| Series C | 1 |
| Series D+ | 1 |
Countries
by dealsGrand Pharma — countries — interactive chart.
Data table
| Grand Pharma — countries | |
|---|---|
| Belgium | 1 |
| Italy | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| InnovHeart | Italy | 1 | €49M |
| eTheRNA | Belgium | 1 | €39M |
| Xeltis | Switzerland | 1 | €32M |